Mather Group, Llc. Bristol Myers Squibb CO Transaction History

Mather Group, Llc.

$7.74 Billion
Q3 2024

A detailed history of Mather Group, Llc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Mather Group, Llc. holds 6,950 shares of BMY stock, worth $390,729. This represents 0.0% of its overall portfolio holdings.

Number of Shares

6,950

Previous 15,763 55.91%

Holding current value

$390,729

Previous $654,000 45.11%

% of portfolio

0.0%

Previous 0.01%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 07, 2024	SELL	$39.66 - $51.75 $349,523 - $456,072	-8,813 Reduced 55.91%	6,950 $359,000
Q2 2024 Jul 08, 2024	SELL	$40.25 - $52.99 $398,434 - $524,548	-9,899 Reduced 38.57%	15,763 $654,000
Q1 2024 Apr 08, 2024	SELL	$47.98 - $54.4 $2,830 - $3,209	-59 Reduced 0.23%	25,662 $1.39 Million
Q4 2023 Feb 05, 2024	BUY	$48.48 - $57.85 $82,222 - $98,113	1,696 Added 7.06%	25,721 $1.32 Million
Q3 2023 Nov 13, 2023	SELL	$57.89 - $64.73 $75,083 - $83,954	-1,297 Reduced 5.12%	24,025 $1.39 Million
Q2 2023 Aug 08, 2023	SELL	$63.71 - $70.74 $28,669 - $31,832	-450 Reduced 1.75%	25,322 $1.62 Million
Q1 2023 May 09, 2023	BUY	$65.71 - $74.53 $1.04 Million - $1.18 Million	15,803 Added 158.52%	25,772 $1.79 Million
Q4 2022 Mar 10, 2023	BUY	$68.48 - $81.09 $258,648 - $306,276	3,777 Added 61.0%	9,969 $717,000
Q3 2022 Nov 14, 2022	BUY	$0.13 - $76.84 $310 - $183,570	2,389 Added 62.82%	6,192 $440,000
Q2 2022 Aug 16, 2022	BUY	$72.62 - $79.98 $276,173 - $304,163	3,803 New	3,803 $293,000
Q3 2021 Nov 04, 2021	SELL	$59.17 - $69.31 $220,822 - $258,664	-3,732 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$61.91 - $67.42 $12,010 - $13,079	194 Added 5.48%	3,732 $249,000
Q1 2021 May 14, 2021	BUY	$59.34 - $66.74 $209,944 - $236,126	3,538 New	3,538 $223,000

Others Institutions Holding BMY

# of Institutions

2,533

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $120B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mather Group, Llc., based on Form 13F filings with the SEC.

News

Stay updated on Mather Group, Llc. with notifications on news.

Account